Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

Thrombophilic mutations as risk factor for retinal vein occlusion: a case-control study.

Russo PD, Damante G, Pasca S, Turello M, Barillari G.

Clin Appl Thromb Hemost. 2015 May;21(4):373-7. doi: 10.1177/1076029614522544. Epub 2014 Feb 25.

PMID:
24569626
2.

Analysis of thrombophilic genetic mutations in patients with Sheehan's syndrome: is thrombophilia responsible for the pathogenesis of Sheehan's syndrome?

Gokalp D, Tuzcu A, Bahceci M, Ayyildiz O, Yurt M, Celik Y, Alpagat G.

Pituitary. 2011 Jun;14(2):168-73. doi: 10.1007/s11102-010-0276-x.

PMID:
21107737
3.

Heritable thrombophilia and hypofibrinolysis. Possible causes of retinal vein occlusion.

Glueck CJ, Bell H, Vadlamani L, Gupta A, Fontaine RN, Wang P, Stroop D, Gruppo R.

Arch Ophthalmol. 1999 Jan;117(1):43-9.

PMID:
9930159
4.

Thrombophilic risk factors in different types of retinal vein occlusion in Tunisian patients.

Mrad M, Fekih-Mrissa N, Wathek C, Rannen R, Gabsi S, Gritli N.

J Stroke Cerebrovasc Dis. 2014 Jul;23(6):1592-8. doi: 10.1016/j.jstrokecerebrovasdis.2013.12.048. Epub 2014 Mar 14.

PMID:
24630828
5.

Thrombophilic mutations and risk of retinal vein occlusion.

Biancardi AL, Gadelha T, Borges WI, Vieira de Moraes H Jr, Spector N.

Arq Bras Oftalmol. 2007 Nov-Dec;70(6):971-4.

6.

MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risks factor for youth retinal vein occlusion.

Cruciani F, Moramarco A, Curto T, Labate A, Recupero V, Conti L, Gandolfo GM, Balacco Gabrieli C.

Clin Ter. 2003 Sep-Oct;154(5):299-303.

PMID:
14994919
8.

Genetic polymorphisms associated with retinal vein occlusion: a Greek case-control study and meta-analysis.

Yioti GG, Panagiotou OA, Vartholomatos GA, Kolaitis NI, Pappa CN, Evangelou E, Stefaniotou MI.

Ophthalmic Genet. 2013 Sep;34(3):130-9. doi: 10.3109/13816810.2012.746376. Epub 2013 Jan 4.

PMID:
23289804
9.

The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion.

Dodson PM, Haynes J, Starczynski J, Farmer J, Shigdar S, Fegan G, Johnson RJ, Fegan C.

Eye (Lond). 2003 Aug;17(6):772-7.

PMID:
12928694
10.

Associations of thrombophilia, hypofibrinolysis, and retinal vein occlusion.

Glueck CJ, Wang P, Bell H, Rangaraj V, Goldenberg N.

Clin Appl Thromb Hemost. 2005 Oct;11(4):375-89.

PMID:
16244763
11.

Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.

Kuhli-Hattenbach C, Hellstern P, Nägler DK, Kohnen T, Hattenbach LO.

Ophthalmic Genet. 2017 Jan 13:1-5. doi: 10.1080/13816810.2016.1244694. [Epub ahead of print]

PMID:
28085526
12.

Do thrombophilic gene mutations have a role on thromboembolic events in cancer patients?

Ozkan M, Sivgin S, Kocyigit I, Emirogullari F, Dikilitas M, Kaynar L, Ozkul Y, Er O.

Asia Pac J Clin Oncol. 2012 Sep;8(3):e34-41. doi: 10.1111/j.1743-7563.2012.01536.x. Epub 2012 May 15.

PMID:
22898008
13.

Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.

Mueller T, Marschon R, Dieplinger B, Haidinger D, Gegenhuber A, Poelz W, Webersinke G, Haltmayer M.

J Vasc Surg. 2005 May;41(5):808-15.

14.

A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.

Almawi WY, Tamim H, Kreidy R, Timson G, Rahal E, Nabulsi M, Finan RR, Irani-Hakime N.

J Thromb Thrombolysis. 2005 Jun;19(3):189-96.

PMID:
16082606
15.

Plasminogen activator inhibitor-1, factor V, factor II and methylenetetrahydrofolate reductase polymorphisms in women with recurrent miscarriage.

Pietropolli A, Giuliani E, Bruno V, Patrizi L, Piccione E, Ticconi C.

J Obstet Gynaecol. 2014 Apr;34(3):229-34. doi: 10.3109/01443615.2013.836476. Epub 2014 Jan 31.

PMID:
24484533
16.

Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors.

Janssen MC, den Heijer M, Cruysberg JR, Wollersheim H, Bredie SJ.

Thromb Haemost. 2005 Jun;93(6):1021-6. Review.

PMID:
15968383
17.
18.

A prospective case-control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss.

Yenicesu GI, Cetin M, Ozdemir O, Cetin A, Ozen F, Yenicesu C, Yildiz C, Kocak N.

Am J Reprod Immunol. 2010 Feb;63(2):126-36. doi: 10.1111/j.1600-0897.2009.00770.x. Epub 2009 Nov 10.

PMID:
19906129
19.

Prevalence of factor V G1691A (Leiden), prothrombin G20210A, and methylene tetrahydrofolate reductase C677T thrombophilic mutations in children with inflammatory bowel disease.

Kader HA, Berman WF, Al-Seraihy AS, Ware RE, Ulshen MH, Treem WR.

J Pediatr Gastroenterol Nutr. 2002 Nov;35(5):629-35.

PMID:
12454577
20.

[Factor V Leiden, FII G20210A, MTHFR C677T mutations as risk factors for venous thrombosis during pregnancy and puerperium].

Dordević V, Rakićević L, Spasić M, Miković D, Kovać M, Radojković D.

Vojnosanit Pregl. 2005 Mar;62(3):201-5. Serbian.

PMID:
15790048

Supplemental Content

Support Center